Team | NEWDIGS Initiative at MIT

Strategic Advisors

Deborah Ancona, PhD Seley Distinguished Professor of Management; Professor of Organization Studies; Faculty Director, MIT Leadership Center, MIT Sloan School of Management	Retsef Levi, PhD J. Spencer Standish (1945) Professor of Management; Associate Professor of Operations Management, MIT Sloan School of Management
Denny A. Ausiello, MD CATCH Co-Founder, Director; Jackson Professor of Clinical Medicine, Harvard Medical School; Chief of Medicine, MGH; Director, Pfizer	Andrew Lo, PhD Charles E. and Susan T. Harris Professor of Finance; Director, Laboratory for Financial Engineering, MIT Sloan School of Management
Ernest Berndt, PhD, MS Louis E Seley Professor of Applied Economics, Sloan School of Management; Co-director Biomedical Enterprise Program	Alex 'Sandy' Pentland, PhD Professor of Media Arts and Sciences, Toshiba Professor, MIT Media Lab; Director, MIT Media Lab Entrepreneurship Program
Charles L. Cooney, PhD Robert T. Haslam Professor of Chemical Engineering, MIT; Faculty Director, Deshpande Center for Technological Innovation	Ram Sasisekharan, PhD Director, Harvard – MIT Health Sciences and Technology, Edward Hood Taplin Professor of Health Sciences & Technology and Biological Engineering, MIT
Michael A. Cusumano, PhD Sloan Management Review Distinguished Professor of Management, MIT Sloan School of Management	Phillip A. Sharp, PhD Institute Professor, Koch Institute for Integrative Cancer Research, MIT
Elazer Edelman, MD, PhD, FACC Thomas D & Virginia W Cabot Professor of HST, Health Sciences and Technology Program, MIT	Anthony Sinskey, ScD Faculty Director, CBI; Professor of Biology and Health Sciences and Technology, MIT

Executive Advisory Network

The role of the Executive Advisory Network is to contribute ideas for projects, vet new opportunities, and disseminate emerging insights and recommendations from NEWDIGS activities. The Executive Advisory Network will assist with outreach to potential sponsors and endorse the goals of NEWDIGS projects as well the alignment of new projects with NEWDIGS mission and priorities; It has no financial or fiduciary responsibility, nor does it make any product-specific decisions. Typical agenda items include research updates, workshop opportunities, new mini-consortia proposals and pending publications.

Nick Crabb, PhD Program Director, Scientific Affairs National Institute for Health & Clinical Excellence (NICE)	Kenneth A. Oye, PhD Associate Professor of Political Science and Engineering Systems;; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology
Anne-Virginie Eggimann, MSc Vice President, Regulatory Science bluebird bio	Peter L. Saltonstall President and CEO National Organization for Rare Disorders (NORD)
Hans-Georg Eichler, MD, MSc Senior Medical Officer European Medicines Agency	Harry Selker, MD, MSPH Dean, Clinical and Translational Science Institute Institute for Clinical Research & Health Policy Studies Tufts University
Gigi Hirsch, MD Executive Director, Center for Biomedical Innovation, NEWDIGS	David R. Strutton, PhD Vice President of Global Pharmaceuticals and Policy Research, Center for Observational and Real-World Evidence, Merck & Co., Inc.
Hilary M. Malone, PhD Chief Regulatory Officer, Head of Global Regulatory Affairs Sanofi	Mark Trusheim, MSc Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting

Affiliated Faculty and Researchers

Jane F. Barlow, MD, MPH, MBA Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project; CEO, Jane Barlow & Associates	Judy Maro, PhD, MS Research Affiliate, Center for Biomedical Innovation, Research Fellow in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute
Ernest Berndt, PhD, MS Louis E Seley Professor of Applied Economics, Sloan School of Management; Co-director Biomedical Enterprise Program	Kenneth A. Oye, PhD Associate Professor of Political Science and Engineering Systems;; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology
Stella Blackburn, MD, MA, MSc Senior Advisor, Regulatory Science, NEWDIGS; Honorary Associate Professor, London School of Hygiene & Tropical Medicine; Vice President, Global Head of Early Access and Risk Management, IQVIA	Nitin R. Patel, PhD Research Affiliate, MIT Center for Biomedical Innovation; Founder, Chairman, and Chief Technology Officer, Cytel Statistical Software and Services
Jeff Brown, PhD Assistant Professor, Department of Population Medicine, Harvard Medical School	Casey Quinn, PhD Research Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
Chester Drum, MD, PhD Assistant Professor, Department of Medicine, National University of Singapore	G.K. Raju, PhD CBI Distinguished Fellow; Chairman, CBI Biomanufacturing Steering Committee; Executive Director, MIT Pharmaceutical Manufacturing Initiative
R. John Glasspool Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project	Mark Trusheim, MSc Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting

NEWDIGS Program Leadership

Azrina Azhar, MS, MPA azrina@mit.edu Operations Manager, NEWDIGS 617-324-9640	Eric A. Small easmall@mit.edu Senior Administrative Assistant, NEWDIGS; Assistant to Executive Director Gigi Hirsch 617-324-4841
David P. Fritsche, MBA dpfritsc@mit.edu Technology Officer, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project 617-324-7763	Mark Trusheim, MSc trusheim@mit.edu Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting
Gigi Hirsch, MD ghirsch@mit.edu Executive Director, Center for Biomedical Innovation, NEWDIGS 617-253-9609	Colin Young, PhD colyoung@mit.edu Director, Drug Development Pipeline Research, Financing and Reimbursement of Cures in the US (FoCUS) 617-324-7261
Karen Katz, JD kkatz@mit.edu Director, Financing and Reimbursement of Cures in the US (FoCUS) Project 617-324-8324	Deborah L. Young, EMBA, Ed.M. debyoung@mit.edu Director of Operations, MIT Center for Biomedical Innovation: NEWDIGS 617-324-7756
Kay Larholt, ScD klarholt@mit.edu Director of Research, NEWDIGS 617-253-7333

FoCUS Project Team

Financing and Reimbursement of Cures in the U.S.

Jane F. Barlow, MD, MPH, MBA Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project; CEO, Jane Barlow & Associates jfbarlow@mit.edu	Casey Quinn, PhD Research Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project caquinn@mit.edu
Matt W. Courtney, M.Ed Communications Assistant, Financing and Reimbursement of Cures in the US (FoCUS) 617-715-5475 mcourtny@mit.edu	Jonathan Salcedo, MA USC/NEWDIGS Research Fellow, Financing and Reimbursement of Cures in the US (FoCUS) Project salcedo@mit.edu
R. John Glasspool Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project focusteam@mit.edu	Katie Torrence Project Coordinator, Financing and Reimbursement of Cures in the US (FoCUS) 617-324-2695 ktorrenc@mit.edu
Aaron Hill, PhD Research Associate, Patient Perspective, Financing and Reimbursement of Cures in the US (FoCUS) Project 617-258-0534 adhill@mit.edu	Mark Trusheim, MSc Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting trusheim@mit.edu
Gigi Hirsch, MD Executive Director, Center for Biomedical Innovation, NEWDIGS 617-253-9609 ghirsch@mit.edu	Colin Young, PhD Director, Drug Development Pipeline Research, Financing and Reimbursement of Cures in the US (FoCUS) 617-324-7261 colyoung@mit.edu
Karen Katz, JD Director, Financing and Reimbursement of Cures in the US (FoCUS) Project 617-324-8324 kkatz@mit.edu

LEAPS Project Team

Bryan Burgos Researcher, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project bryanb@mit.edu	Kay Larholt, ScD Director of Research, NEWDIGS 617-253-7333 klarholt@mit.edu
Fiona X. Cai Researcher, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project fcai@mit.edu	Kevin Nam, PhD, MS Researcher, Dynamic Dossier in the Cloud (a LEAPS Incubator Project)
David P. Fritsche, MBA Technology Officer, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project 617-324-7763 dpfritsc@mit.edu	Donna Palmer, PhD Program Manager, Dynamic Dossier in the Cloud (a LEAPS Incubator project) dtpalmer@mit.edu
Gigi Hirsch, MD Executive Director, Center for Biomedical Innovation, NEWDIGS 617-253-9609 ghirsch@mit.edu	Mitesh Puthran Data Analyst, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project miteshp@mit.edu
Keileen Hopps, MPA Project Coordinator, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project 617-324-7763 khopps@mit.edu	Mark Trusheim, MSc Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting trusheim@mit.edu

Strategic Advisory Network

Anna D. Barker, PhD Co-Director, Complex Adaptive Systems (CAS); Director, National Biomarker Development Alliance (NBDA); Professor, School of Life Sciences, Arizona State University (ASU)	Secretary Marylou Sudders, MS, Hon.DSc Secretary of Health and Human Services, Commonwealth of Massachusetts
Alex 'Sandy' Pentland, PhD Professor of Media Arts and Sciences, Toshiba Professor, MIT Media Lab; Director, MIT Media Lab Entrepreneurship Program	Peter Szolovits, PhD Professor, Department of Electrical Engineering and Computer Science (EECS), Institute for Medical Engineering and Science (IMES), Massachusetts Institute of Technology
Richard Platt, MD, MSc Executive Director, Harvard Pilgrim Health Care Institute, Department of Population Medicine, Harvard Medical School	Susan Windham-Bannister, PhD President & CEO, Biomedical Growth Strategies LLC; Managing Partner, Biomedical Innovation Advisors LLC
Michael S. Sherman, MD, MBA, MS, CPE Senior Vice President & Chief Medical Officer; Harvard Pilgrim Health Care	Janet Woodcock, MD Director, Center for Drug Evaluation and Research, US Food and Drug Administration